🇺🇸 FDA
Patent

US 12071442

Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists

granted A61PA61P35/00

Quick answer

US patent 12071442 (Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists) held by Nimbus Saturn, Inc. expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nimbus Saturn, Inc.
Grant date
Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P35/00